Literature DB >> 10610833

Do prostaglandins have a salutary role in skeletal muscle ischaemia-reperfusion injury?

T E Rowlands1, M J Gough, S Homer-Vanniasinkam.   

Abstract

OBJECTIVES: the effects of prostaglandins (PG) E1, E2, and the prostacyclin analogue iloprost with and without the addition of free-radical scavengers catalase and superoxide dismutase on gastrocnemius blood flow and oedema were studied in a rodent model of hindlimb ischaemia-reperfusion.
METHODS: male Sprague-Dawley rats underwent 6-h hindlimb ischaemia with 4-h reperfusion. Prostaglandins were infused prior to reperfusion and their effects on limb blood flow and oedema examined.
RESULTS: control animals exhibited a triphasic pattern of muscle blood flow during reperfusion compared to normal animals. PGE1 did not abolish low reflow at 10 min, relative reperfusion was preserved but reperfusion injury was abolished at 120 min. Muscle blood flow was increased at 240 min compared to controls. Increased limb swelling was also seen. Addition of free-radical scavengers caused the abolition of low reflow. Similar results were seen with iloprost. PGE2 abolished low reflow at 10 min and increased perfusion at 120 min but did not prevent reperfusion injury at 240 min.
CONCLUSIONS: PGE1 and iloprost enhance muscle blood flow at 4-h reperfusion, though neither abolishes low reflow; PGE2 improved flow at 10 and 120 min but not after 240 min. This study demonstrates a potentially beneficial role for prostaglandins in improving muscle blood flow in skeletal muscle ischaemia-reperfusion injury. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10610833     DOI: 10.1053/ejvs.1999.0929

Source DB:  PubMed          Journal:  Eur J Vasc Endovasc Surg        ISSN: 1078-5884            Impact factor:   7.069


  4 in total

1.  The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgery.

Authors:  Gaetano de Donato; Gualberto Gussoni; Gianmarco de Donato; Giuseppe Maria Andreozzi; Erminio Bonizzoni; Antonino Mazzone; Attilio Odero; Giovanni Paroni; Carlo Setacci; Piergiorgio Settembrini; Fabrizio Veglia; Romeo Martini; Francesco Setacci; Domenico Palombo
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

2.  Effects of ischemic preconditioning and iloprost on myocardial ischemia-reperfusion damage in rats.

Authors:  Yasin Ay; Ibrahim Kara; Cemalettin Aydin; Nuray Kahraman Ay; Melike Elif Teker; Serkan Senol; Bekir Inan; Halil Basel; Omer Uysal; Rahmi Zeybek
Journal:  Int J Clin Exp Med       Date:  2013-08-01

Review 3.  Improving the ischemia-reperfusion injury in vascularized composite allotransplantation: Clinical experience and experimental implications.

Authors:  Jiqiang He; Umar Zeb Khan; Liming Qing; Panfeng Wu; Juyu Tang
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

4.  Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia-reperfusion injury in rats.

Authors:  Dilek Erer; Abdullah Özer; Hüseyin Demirtaş; İpek Işık Gönül; Halil Kara; Hande Arpacı; Faruk Metin Çomu; Gürsel Levent Oktar; Mustafa Arslan; Ayşegül Küçük
Journal:  Drug Des Devel Ther       Date:  2016-08-19       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.